Zimmer Biomet Holdings, Inc.

ZBH Healthcare Medical Devices

Zimmer Biomet Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $8.2 billion, up 7.20% from fiscal 2024. In the quarter to June 2026, revenue grew 4.80%, EPS grew 33.8%, free cash flow grew 13.1% and total debt fell 1.23%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for five.

95.06 0.68 +0.72%
Market cap
$18.0B
P/E
23.0×
Fwd P/E
17.7×
Dividend yield
1.01%
F-score
6/9
Altman Z
2.38
Beneish M
−2.59
Dividend safety
72/100
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
ROE
6.41% 6.07% 5.60% 6.40%

+8 more TTM periods

Piotroski F-Score
6 6 6 6
ROA
3.53% 3.39% 3.17% 3.56%
ROIC
3.82% 3.74% 3.50% 4.25%
Return on Tangible Assets
18.67% 17.66% 14.87% 14.31%
Average Days of Receivables
75.91 75.03 75.58 72.82
Free Cash Flow per Share
5.39 5.17 5.44 5.11
Free Cash Flow
1,036.50 1,008.10 1,077.30 1,011.30
Other line items

Show all line items

Columns are period end dates